Integrated Genomics Identifies Convergence of Ankylosing Spondylitis with Global Immune Mediated Disease Pathways

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Uddin, Mohammed ^a   Codner, Dianne ^b   Mahmud Hasan, S M ^b   Scherer, Stephen W ^a,c,d   O'Rielly, Darren D ^b   Rahman, Proton ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

STAT2 PROTEIN; STAT3 PROTEIN;

DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; IMMUNITY; METABOLISM; MUTATION; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPONDYLITIS, ANKYLOSING;

DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; IMMUNITY; MUTATION; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION; SPONDYLITIS, ANKYLOSING; STAT2 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84929429316     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10314     Document Type: Article

References (43)

1. Masi, A. T. Might axial myofascial properties and biomechanical mechanisms be relevant to ankylosing spondylitis and axial spondyloarthritis? Arthritis Res. Ther. 16, 107, doi:10.1186/ar4532 (2014).
2. Choi, C. B. et al. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Ann. Rheum. Dis. 69, 582-584, doi:10.1136/ard.2008.105296 (2010).
3. Danoy, P. et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS genetics 6, e1001195, doi:10.1371/journal.pgen.1001195 (2010).
4. Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature genetics 43, 761-767, doi:10.1038/ng.873 (2011).
5. International Genetics of Ankylosing Spondylitis, C. et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature genetics 45, 730-738, doi:10.1038/ng.2667 (2013).
6. Uddin, M. et al. UGT2B17 copy number gain in a large ankylosing spondylitis multiplex family. BMC genetics 14, 67, doi:10.1186/1471-2156-14-67 (2013).
7. Brown, M. A. Progress in the genetics of ankylosing spondylitis. Briefings in functional genomics 10, 249-257, doi:10.1093/bfgp/elr023 (2011).
8. Visscher, P. M., Brown, M. A., McCarthy, M. I. & Yang, J. Five years of GWAS discovery. Am. J. Hum. Genet. 90, 7-24, doi:10.1016/j.ajhg.2011.11.029 (2012).
9. Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nature reviews. Genetics 14, 661-673, doi:10.1038/nrg3502 (2013).
10. Uddin, M. et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nature genetics 46, 742-747, doi:10.1038/ng.2980 (2014).
11. O'Roak, B. J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250, doi:10.1038/nature10989 (2012).
12. Parikshak, N. N. et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155, 1008-1021, doi:10.1016/j.cell.2013.10.031 (2013).
13. Willsey, A. J. et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155, 997-1007, doi:10.1016/j.cell.2013.10.020 (2013).
14. Stevens, A., Meyer, S., Hanson, D., Clayton, P. & Donn, R. P. Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis. Arthritis Res. Ther. 16, R109, doi:10.1186/ar4559 (2014).
15. Hannum, G. et al. Genome-wide association data reveal a global map of genetic interactions among protein complexes. PLoS genetics 5, e1000782, doi:10.1371/journal.pgen.1000782 (2009).
16. Perera, G. K. et al. Integrative biology approach identifies cytokine targeting strategies for psoriasis. Science translational medicine 6, 223ra222, doi:10.1126/scitranslmed.3007217 (2014).
17. Rossin, E. J. et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS genetics 7, e1001273, doi:10.1371/journal.pgen.1001273 (2011).
18. MacArthur, D. G. et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 335, 823-828, doi:10.1126/science.1215040 (2012).
19. Richette, P. et al. Psoriasis and phenotype of patients with early inflammatory back pain. Ann. Rheum. Dis. 72, 566-571, doi:10.1136/annrheumdis-2012-201610 (2013).
20. Shivashankar, R. et al. Incidence of Spondyloarthropathy in patients with ulcerative colitis: a population-based study. J. Rheumatol. 40, 1153-1157, doi:10.3899/jrheum.121029 (2013).
21. Thjodleifsson, B., Geirsson, A. J., Bjornsson, S. & Bjarnason, I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis and rheumatism 56, 2633-2639, doi:10.1002/art.22812 (2007).
22. Wang, X., Lin, Z., Wei, Q., Jiang, Y. & Gu, J. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatology international 29, 1343-1347, doi:10.1007/s00296-009-0883-x (2009).
23. Duftner, C. et al. Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis. Ann. Rheum. Dis. 65, 647-653, doi:10.1136/ard.2005.042085 (2006).
24. Poddubnyy, D. A. et al. Relation of HLA-B27, tumor necrosis factor-alpha promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis - a comprehensive genotype-phenotype analysis from an observational cohort. J. Rheumatol. 38, 2436-2441, doi:10.3899/jrheum.110130 (2011).
25. Bal, A. et al. Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clinical rheumatology 26, 211-215, doi:10.1007/s10067-006-0283-5 (2007).
26. Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nature genetics 41, 199-204, doi:10.1038/ng.311 (2009).
27. Wang, K. et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am. J. Hum. Genet. 84, 399-405, doi:10.1016/j.ajhg.2009.01.026 (2009).
28. Axtell, R. C. et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nature medicine 16, 406-412, doi:10.1038/nm.2110 (2010).
29. Wei, L., Laurence, A., Elias, K. M. & O'Shea, J. J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282, 34605-34610, doi:10.1074/jbc.M705100200 (2007).
30. Sutton, C. E., Mielke, L. A. & Mills, K. H. IL-17-producing gammadelta T cells and innate lymphoid cells. European journal of immunology 42, 2221-2231, doi:10.1002/eji.201242569 (2012).
31. Cua, D. J. & Tato, C. M. Innate IL-17-producing cells: the sentinels of the immune system. Nature reviews. Immunology 10, 479-489, doi:10.1038/nri2800 (2010).
32. Flanagan, S. E. et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nature genetics 46, 812-814, doi:10.1038/ng.3040 (2014).
33. Fu, W. et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220, doi:10.1038/nature11690 (2013).
34. Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245, doi:10.1038/nature11011 (2012).
35. Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241, doi:10.1038/nature10945 (2012).
36. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299, doi:10.1016/j.neuron.2012.04.009 (2012).
37. Jiang, Y. H. et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 93, 249-263, doi:10.1016/j.ajhg.2013.06.012 (2013).
38. O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature genetics 43, 585-589, doi:10.1038/ng.835 (2011).
39. Martin, A. R. et al. Transcriptome sequencing from diverse human populations reveals differentiated regulatory architecture. PLoS genetics 10, e1004549, doi:10.1371/journal.pgen.1004549 (2014).
40. Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575-581, doi:10.1038/nature13302 (2014).
41. Zuberi, K. et al. GeneMANIA prediction server 2013 update. Nucleic acids research 41, W115-122, doi:10.1093/nar/gkt533 (2013).
42. Halldorsson, B. V. & Sharan, R. Network-based interpretation of genomic variation data. J. Mol. Biol. 425, 3964-3969, doi:10.1016/j.jmb.2013.07.026 (2013).
43. Koh, G. C., Porras, P., Aranda, B., Hermjakob, H. & Orchard, S. E. Analyzing protein-protein interaction networks. J. Proteome. Res. 11, 2014-2031, doi:10.1021/pr201211w (2012).